Semiconductors
Compare Stocks
4 / 10Stock Comparison
QUIK vs MRAM vs AEHR vs ACLS
Revenue, margins, valuation, and 5-year total return — side by side.
Semiconductors
Semiconductors
Semiconductors
QUIK vs MRAM vs AEHR vs ACLS — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Semiconductors | Semiconductors | Semiconductors | Semiconductors |
| Market Cap | $294M | $502M | $2.79B | $4.88B |
| Revenue (TTM) | $16M | $57M | $49M | $845M |
| Net Income (TTM) | $-9M | $284K | $-11M | $101M |
| Gross Margin | 36.7% | 51.5% | 30.2% | 43.6% |
| Operating Margin | -55.0% | -12.8% | -27.8% | 11.6% |
| Forward P/E | — | 1079.6x | — | 44.7x |
| Total Debt | $22M | $3M | $11M | $42M |
| Cash & Equiv. | $22M | $44M | $25M | $145M |
QUIK vs MRAM vs AEHR vs ACLS — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| QuickLogic Corporat… (QUIK) | 100 | 404.3 | +304.3% |
| Everspin Technologi… (MRAM) | 100 | 458.2 | +358.2% |
| Aehr Test Systems (AEHR) | 100 | 5892.7 | +5792.7% |
| Axcelis Technologie… (ACLS) | 100 | 607.2 | +507.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: QUIK vs MRAM vs AEHR vs ACLS
Each card shows where this stock fits in a portfolio — not just who wins on paper.
QUIK lags the leaders in this set but could rank higher in a more targeted comparison.
MRAM is the #2 pick in this set and the best alternative if growth exposure is your priority.
- Rev growth 9.5%, EPS growth -173.9%, 3Y rev CAGR -2.7%
- 9.5% revenue growth vs AEHR's -20.2%
AEHR is the clearest fit if your priority is long-term compounding.
- 70.3% 10Y total return vs ACLS's 15.1%
- +9.9% vs ACLS's +173.2%
ACLS carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.
- Dividend streak 0 yrs, beta 2.00
- Lower volatility, beta 2.00, Low D/E 4.1%, current ratio 4.77x
- Beta 2.00, current ratio 4.77x
- Better valuation composite
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 9.5% revenue growth vs AEHR's -20.2% | |
| Value | Better valuation composite | |
| Quality / Margins | 11.9% margin vs QUIK's -58.3% | |
| Stability / Safety | Beta 2.00 vs AEHR's 4.77, lower leverage | |
| Dividends | Tie | None of these 4 stocks pay a meaningful dividend |
| Momentum (1Y) | +9.9% vs ACLS's +173.2% | |
| Efficiency (ROA) | 7.5% ROA vs QUIK's -18.6%, ROIC 9.6% vs -13.0% |
QUIK vs MRAM vs AEHR vs ACLS — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
QUIK vs MRAM vs AEHR vs ACLS — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
ACLS leads in 2 of 6 categories
AEHR leads 1 • QUIK leads 0 • MRAM leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — MRAM and ACLS each lead in 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ACLS is the larger business by revenue, generating $845M annually — 53.7x QUIK's $16M. ACLS is the more profitable business, keeping 11.9% of every revenue dollar as net income compared to QUIK's -58.3%. On growth, MRAM holds the edge at +13.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $16M | $57M | $49M | $845M |
| EBITDAEarnings before interest/tax | -$4M | -$4M | -$10M | $111M |
| Net IncomeAfter-tax profit | -$9M | $284,000 | -$11M | $101M |
| Free Cash FlowCash after capex | -$7M | -$1M | -$14M | $90M |
| Gross MarginGross profit ÷ Revenue | +36.7% | +51.5% | +30.2% | +43.6% |
| Operating MarginEBIT ÷ Revenue | -55.0% | -12.8% | -27.8% | +11.6% |
| Net MarginNet income ÷ Revenue | -58.3% | +0.5% | -22.7% | +11.9% |
| FCF MarginFCF ÷ Revenue | -46.3% | -2.1% | -28.1% | +10.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | -52.5% | +13.2% | -26.5% | +3.3% |
| EPS Growth (YoY)Latest quarter vs prior year | -71.4% | +74.4% | -2.2% | -65.9% |
Valuation Metrics
ACLS leads this category, winning 4 of 5 comparable metrics.
Valuation Metrics
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $294M | $502M | $2.8B | $4.9B |
| Enterprise ValueMkt cap + debt − cash | $294M | $461M | $2.8B | $4.8B |
| Trailing P/EPrice ÷ TTM EPS | -67.54x | -827.31x | -702.00x | 41.75x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 1079.60x | — | 44.69x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | 1.98x |
| EV / EBITDAEnterprise value multiple | — | — | — | 34.85x |
| Price / SalesMarket cap ÷ Revenue | 14.64x | 9.09x | 47.39x | 5.81x |
| Price / BookPrice ÷ Book value/share | 10.24x | 7.04x | 21.97x | 4.86x |
| Price / FCFMarket cap ÷ FCF | — | 160.68x | — | 45.56x |
Profitability & Efficiency
ACLS leads this category, winning 8 of 9 comparable metrics.
Profitability & Efficiency
ACLS delivers a 9.8% return on equity — every $100 of shareholder capital generates $10 in annual profit, vs $-35 for QUIK. ACLS carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to QUIK's 0.88x. On the Piotroski fundamental quality scale (0–9), ACLS scores 5/9 vs AEHR's 1/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | -35.4% | +0.4% | -8.5% | +9.8% |
| ROA (TTM)Return on assets | -18.6% | +0.3% | -7.5% | +7.5% |
| ROICReturn on invested capital | -13.0% | -18.4% | -3.0% | +9.6% |
| ROCEReturn on capital employed | -15.4% | -9.4% | -3.2% | +10.4% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 4 | 1 | 5 |
| Debt / EquityFinancial leverage | 0.88x | 0.05x | 0.09x | 0.04x |
| Net DebtTotal debt minus cash | -$19,000 | -$41M | -$14M | -$103M |
| Cash & Equiv.Liquid assets | $22M | $44M | $25M | $145M |
| Total DebtShort + long-term debt | $22M | $3M | $11M | $42M |
| Interest CoverageEBIT ÷ Interest expense | -21.26x | — | — | 77.10x |
Total Returns (Dividends Reinvested)
AEHR leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in AEHR five years ago would be worth $398,515 today (with dividends reinvested), compared to $28,232 for QUIK. Over the past 12 months, AEHR leads with a +991.6% total return vs ACLS's +173.2%. The 3-year compound annual growth rate (CAGR) favors AEHR at 50.7% vs ACLS's 9.7% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +179.6% | +113.8% | +311.8% | +84.2% |
| 1-Year ReturnPast 12 months | +210.2% | +266.4% | +991.6% | +173.2% |
| 3-Year ReturnCumulative with dividends | +217.0% | +195.5% | +242.3% | +32.2% |
| 5-Year ReturnCumulative with dividends | +182.3% | +312.1% | +3885.1% | +286.8% |
| 10-Year ReturnCumulative with dividends | +25.4% | +168.2% | +7029.7% | +1505.9% |
| CAGR (3Y)Annualised 3-year return | +46.9% | +43.5% | +50.7% | +9.7% |
Risk & Volatility
Evenly matched — MRAM and ACLS each lead in 1 of 2 comparable metrics.
Risk & Volatility
ACLS is the less volatile stock with a 2.00 beta — it tends to amplify market swings less than AEHR's 4.77 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. MRAM currently trades 94.8% from its 52-week high vs AEHR's 89.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.37x | 3.14x | 4.86x | 2.17x |
| 52-Week HighHighest price in past year | $18.98 | $22.69 | $102.48 | $171.60 |
| 52-Week LowLowest price in past year | $4.80 | $5.49 | $8.06 | $55.81 |
| % of 52W HighCurrent price vs 52-week peak | +92.5% | +94.8% | +89.1% | +92.5% |
| RSI (14)Momentum oscillator 0–100 | 77.7 | 75.3 | 67.6 | 84.4 |
| Avg Volume (50D)Average daily shares traded | 344K | 1.0M | 3.0M | 734K |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Analyst consensus: QUIK as "Buy", MRAM as "Buy", AEHR as "Hold", ACLS as "Buy". Consensus price targets imply -19.3% upside for ACLS (target: $128) vs -58.2% for MRAM (target: $9).
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | $10.00 | $9.00 | $62.00 | $128.00 |
| # AnalystsCovering analysts | 4 | 5 | 3 | 12 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — |
| Dividend StreakConsecutive years of raises | — | — | — | 0 |
| Dividend / ShareAnnual DPS | — | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +0.0% | +2.5% |
ACLS leads in 2 of 6 categories (Valuation Metrics, Profitability & Efficiency). AEHR leads in 1 (Total Returns). 2 tied.
QUIK vs MRAM vs AEHR vs ACLS: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is QUIK or MRAM or AEHR or ACLS a better buy right now?
For growth investors, Everspin Technologies, Inc.
(MRAM) is the stronger pick with 9. 5% revenue growth year-over-year, versus -17. 6% for Axcelis Technologies, Inc. (ACLS). Axcelis Technologies, Inc. (ACLS) offers the better valuation at 41. 8x trailing P/E (44. 7x forward), making it the more compelling value choice. Analysts rate QuickLogic Corporation (QUIK) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — QUIK or MRAM or AEHR or ACLS?
On forward P/E, Axcelis Technologies, Inc.
is actually cheaper at 44. 7x.
03Which is the better long-term investment — QUIK or MRAM or AEHR or ACLS?
Over the past 5 years, Aehr Test Systems (AEHR) delivered a total return of +38.
9%, compared to +182. 3% for QuickLogic Corporation (QUIK). Over 10 years, the gap is even starker: AEHR returned +75. 0% versus QUIK's +42. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — QUIK or MRAM or AEHR or ACLS?
By beta (market sensitivity over 5 years), Axcelis Technologies, Inc.
(ACLS) is the lower-risk stock at 2. 17β versus Aehr Test Systems's 4. 86β — meaning AEHR is approximately 125% more volatile than ACLS relative to the S&P 500. On balance sheet safety, Axcelis Technologies, Inc. (ACLS) carries a lower debt/equity ratio of 4% versus 88% for QuickLogic Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — QUIK or MRAM or AEHR or ACLS?
By revenue growth (latest reported year), Everspin Technologies, Inc.
(MRAM) is pulling ahead at 9. 5% versus -17. 6% for Axcelis Technologies, Inc. (ACLS). On earnings-per-share growth, the picture is similar: Aehr Test Systems grew EPS 0. 0% year-over-year, compared to -1233. 3% for QuickLogic Corporation. Over a 3-year CAGR, QUIK leads at 16. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — QUIK or MRAM or AEHR or ACLS?
Axcelis Technologies, Inc.
(ACLS) is the more profitable company, earning 14. 3% net margin versus -19. 1% for QuickLogic Corporation — meaning it keeps 14. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ACLS leads at 14. 2% versus -17. 1% for QUIK. At the gross margin level — before operating expenses — QUIK leads at 59. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is QUIK or MRAM or AEHR or ACLS more undervalued right now?
On forward earnings alone, Axcelis Technologies, Inc.
(ACLS) trades at 44. 7x forward P/E versus 1079. 6x for Everspin Technologies, Inc. — 1034. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ACLS: -19. 3% to $128. 00.
08Which pays a better dividend — QUIK or MRAM or AEHR or ACLS?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is QUIK or MRAM or AEHR or ACLS better for a retirement portfolio?
For long-horizon retirement investors, Axcelis Technologies, Inc.
(ACLS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+1550% 10Y return). QuickLogic Corporation (QUIK) carries a higher beta of 2. 37 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ACLS: +1550%, QUIK: +42. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between QUIK and MRAM and AEHR and ACLS?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.